The relative resistance of children to sepsis mortality: from pathways to drug candidates

Abstract Attempts to develop drugs that address sepsis based on leads developed in animal models have failed. We sought to identify leads based on human data by exploiting a natural experiment: the relative resistance of children to mortality from severe infections and sepsis. Using public datasets,...

Full description

Saved in:
Bibliographic Details
Main Authors: Rose B Joachim, Gabriel M Altschuler, John N Hutchinson, Hector R Wong, Winston A Hide, Lester Kobzik
Format: Article
Language:English
Published: Springer Nature 2018-05-01
Series:Molecular Systems Biology
Subjects:
Online Access:https://doi.org/10.15252/msb.20177998
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849331543057629184
author Rose B Joachim
Gabriel M Altschuler
John N Hutchinson
Hector R Wong
Winston A Hide
Lester Kobzik
author_facet Rose B Joachim
Gabriel M Altschuler
John N Hutchinson
Hector R Wong
Winston A Hide
Lester Kobzik
author_sort Rose B Joachim
collection DOAJ
description Abstract Attempts to develop drugs that address sepsis based on leads developed in animal models have failed. We sought to identify leads based on human data by exploiting a natural experiment: the relative resistance of children to mortality from severe infections and sepsis. Using public datasets, we identified key differences in pathway activity (Pathprint) in blood transcriptome profiles of septic adults and children. To find drugs that could promote beneficial (child) pathways or inhibit harmful (adult) ones, we built an in silico pathway drug network (PDN) using expression correlation between drug, disease, and pathway gene signatures across 58,475 microarrays. Specific pathway clusters from children or adults were assessed for correlation with drug‐based signatures. Validation by literature curation and by direct testing in an endotoxemia model of murine sepsis of the most correlated drug candidates demonstrated that the Pathprint‐PDN methodology is more effective at generating positive drug leads than gene‐level methods (e.g., CMap). Pathway‐centric Pathprint‐PDN is a powerful new way to identify drug candidates for intervention against sepsis and provides direct insight into pathways that may determine survival.
format Article
id doaj-art-86ad80da54b44ec7883fcedd89ffa052
institution Kabale University
issn 1744-4292
language English
publishDate 2018-05-01
publisher Springer Nature
record_format Article
series Molecular Systems Biology
spelling doaj-art-86ad80da54b44ec7883fcedd89ffa0522025-08-20T03:46:32ZengSpringer NatureMolecular Systems Biology1744-42922018-05-0114511710.15252/msb.20177998The relative resistance of children to sepsis mortality: from pathways to drug candidatesRose B Joachim0Gabriel M Altschuler1John N Hutchinson2Hector R Wong3Winston A Hide4Lester Kobzik5Department of Environmental Health, Harvard T.H. Chan School of Public HealthDepartment of Neuroscience, Sheffield Institute for Translational Neurosciences, University of SheffieldDepartment of Biostatistics, Harvard T.H. Chan School of Public HealthDivision of Critical Care Medicine, Cincinnati Children's Hospital Medical CenterDepartment of Neuroscience, Sheffield Institute for Translational Neurosciences, University of SheffieldDepartment of Environmental Health, Harvard T.H. Chan School of Public HealthAbstract Attempts to develop drugs that address sepsis based on leads developed in animal models have failed. We sought to identify leads based on human data by exploiting a natural experiment: the relative resistance of children to mortality from severe infections and sepsis. Using public datasets, we identified key differences in pathway activity (Pathprint) in blood transcriptome profiles of septic adults and children. To find drugs that could promote beneficial (child) pathways or inhibit harmful (adult) ones, we built an in silico pathway drug network (PDN) using expression correlation between drug, disease, and pathway gene signatures across 58,475 microarrays. Specific pathway clusters from children or adults were assessed for correlation with drug‐based signatures. Validation by literature curation and by direct testing in an endotoxemia model of murine sepsis of the most correlated drug candidates demonstrated that the Pathprint‐PDN methodology is more effective at generating positive drug leads than gene‐level methods (e.g., CMap). Pathway‐centric Pathprint‐PDN is a powerful new way to identify drug candidates for intervention against sepsis and provides direct insight into pathways that may determine survival.https://doi.org/10.15252/msb.20177998connectivity mapdrug discoverypathwayssepsis
spellingShingle Rose B Joachim
Gabriel M Altschuler
John N Hutchinson
Hector R Wong
Winston A Hide
Lester Kobzik
The relative resistance of children to sepsis mortality: from pathways to drug candidates
Molecular Systems Biology
connectivity map
drug discovery
pathways
sepsis
title The relative resistance of children to sepsis mortality: from pathways to drug candidates
title_full The relative resistance of children to sepsis mortality: from pathways to drug candidates
title_fullStr The relative resistance of children to sepsis mortality: from pathways to drug candidates
title_full_unstemmed The relative resistance of children to sepsis mortality: from pathways to drug candidates
title_short The relative resistance of children to sepsis mortality: from pathways to drug candidates
title_sort relative resistance of children to sepsis mortality from pathways to drug candidates
topic connectivity map
drug discovery
pathways
sepsis
url https://doi.org/10.15252/msb.20177998
work_keys_str_mv AT rosebjoachim therelativeresistanceofchildrentosepsismortalityfrompathwaystodrugcandidates
AT gabrielmaltschuler therelativeresistanceofchildrentosepsismortalityfrompathwaystodrugcandidates
AT johnnhutchinson therelativeresistanceofchildrentosepsismortalityfrompathwaystodrugcandidates
AT hectorrwong therelativeresistanceofchildrentosepsismortalityfrompathwaystodrugcandidates
AT winstonahide therelativeresistanceofchildrentosepsismortalityfrompathwaystodrugcandidates
AT lesterkobzik therelativeresistanceofchildrentosepsismortalityfrompathwaystodrugcandidates
AT rosebjoachim relativeresistanceofchildrentosepsismortalityfrompathwaystodrugcandidates
AT gabrielmaltschuler relativeresistanceofchildrentosepsismortalityfrompathwaystodrugcandidates
AT johnnhutchinson relativeresistanceofchildrentosepsismortalityfrompathwaystodrugcandidates
AT hectorrwong relativeresistanceofchildrentosepsismortalityfrompathwaystodrugcandidates
AT winstonahide relativeresistanceofchildrentosepsismortalityfrompathwaystodrugcandidates
AT lesterkobzik relativeresistanceofchildrentosepsismortalityfrompathwaystodrugcandidates